Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Reexamination Certificate
2011-01-18
2011-01-18
Lukton, David (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
C530S328000, C514S011400
Reexamination Certificate
active
07872097
ABSTRACT:
The present invention relates to a new cyclic peptide compound or a salt thereof, which has anti-hepatitis C virus activities based on inhibitory activity against the RNA replication of hepatitis C virus replicon, to a process for preparation thereof comprising a rearrangement reaction under a mild acidic condition and the following amino acid changing reactions etc., to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or therapeutic treatment of hepatitis C in a human being or an animal.
REFERENCES:
patent: 6927208 (2005-08-01), Wenger et al.
patent: WO 00/01715 (2000-01-01), None
patent: WO 02/32447 (2002-04-01), None
patent: WO 2005/021028 (2005-03-01), None
patent: WO 2005/032576 (2005-04-01), None
patent: WO 2006/038088 (2006-04-01), None
patent: WO 2006/039668 (2006-04-01), None
patent: WO 2006/054801 (2006-05-01), None
Soo Y. Ko, “Solid-Phase Total Synthesis of Cyclosporine Analogues”, Helvetica Chimica Ada, vol. 80, (1997), pp. 695-705.
Marian E. Major, et al., “Hepatitis C Viruses”, Virology 4thEdition, pp. 1127-1161, (2001).
Qui-Lim Choo et al., “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome”, Science, vol. 244, pp. 359-362, (1989).
Markus Thall et al., “Functional Association of Cyclophilin A with HIV-1 Virions”, Nature, vol. 372, pp. 363-365, (1994).
K Inoue et al., “Antiviral Effect of Cyclosporin A on HCV Propagation”, NIH, Jun. 1989, 6thInternational Symposium on Hepatitis C and Related Virus.
Marina Berenguer et al., “HCV-Related Fibrosis Progression Following Liver Transplantation: Increase in Recent Years”, Journal of Hepatology, vol. 32, (2000), pp. 673-684.
Koichi Watashi et al., “Cyclosporin A Suppresses Replication of Hepatitis C Virus Genome in Cultured Hepatocytes”, J. Hepatology, vol. 38, No. 5, pp. 1282-1288 (2003).
Mina Nakagawa et al., “Specific Inhibition of Hepatitis C Virus Replication by Cyclosporin A”, Biochemical and Biophysical Research, vol. 313, No. 1, pp. 42-47 (2004).
Kazutoshi Sakamoto et al., “Taxonomy of the Producing Organism, Fermentation, Isolation, Physico-Chemical Properties and Biological Activities”, The Journal of Antibiotics, vol. 46, No. 12, pp. 1788-1798 (1993).
Office Action dated Mar. 10, 2010, in corresponding Israeli Application No. 190286, Examiner A. Fleider.
Office Action dated May 27, 2010, in corresponding Russian Application No. 2008116674, Examiner M. E. Gorbatovskaya.
Official Action in corresponding Russian Application No. 2008116674, apparent mailing date: Sep. 13, 2010.
Kamijyo Kazunori
Makino Takuya
Neya Masahiro
Tsujii Eisaku
Yamagishi Yukiko
Astellas Pharma Inc.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Lukton David
LandOfFree
Cyclic peptide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic peptide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic peptide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2728508